Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use

Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use

US Patent 12227583 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use ther2025
Bispecific T cell engager and uses thereof2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Targeted compositions2024
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application2024
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of d2024
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof2023